G17* (p.Gly17Ter) variant of GRIA2 (Glutamate receptor 2)
G17* (p.Gly17Ter) in GRIA2 (Glutamate receptor 2) is a protein-truncating change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.84 / 1. The record also includes population frequency data, published literature, and structural context.
G17* (p.Gly17Ter) variant details
- p.Gly17Ter
- gnomAD 4-157221091-G-T
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.845
- CADD 36.00
- Population evidence available
- Structural context available
- Literature evidence available